Assay validation for left-censored data
In laboratory validation studies, it is often important to assess agreement between two assays, based on different techniques. Oftentimes, both assays have lower limits of detection and thus measurements are left censored. For example, in studies of Human Immunodeficiency Virus (HIV), the branched D...
        Saved in:
      
    
          | Published in | Statistics in medicine Vol. 24; no. 21; pp. 3347 - 3360 | 
|---|---|
| Main Authors | , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Chichester, UK
          John Wiley & Sons, Ltd
    
        15.11.2005
     Wiley Subscription Services, Inc  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0277-6715 1097-0258  | 
| DOI | 10.1002/sim.2225 | 
Cover
| Summary: | In laboratory validation studies, it is often important to assess agreement between two assays, based on different techniques. Oftentimes, both assays have lower limits of detection and thus measurements are left censored. For example, in studies of Human Immunodeficiency Virus (HIV), the branched DNA (bDNA) assay was developed to quantify HIV‐1 RNA concentrations in plasma. Validation of newer assays, such as the RT‐PCR (reverse transcriptase polymerase chain reaction) involves assessing agreement of measurements obtained using the two techniques. Both bDNA and RT‐PCR assays have lower limits of detection and thus new statistical methods are needed for assessing agreement between two left‐censored variables. In this paper, we present maximum likelihood and generalized estimating equations approaches to evaluate agreement between two assays that are subject to lower limits of detection. The concordance correlation coefficient is used as an agreement index. The methodology is illustrated using HIV RNA assay data collected as part of a long‐term HIV cohort study. Copyright © 2005 John Wiley & Sons, Ltd. | 
|---|---|
| Bibliography: | Emory University Quadrangle Fund ArticleID:SIM2225 National Institute of Allergy and Infectious Disease ark:/67375/WNG-CBTBQ5DQ-X National Cancer Institute NIH - No. R01 MH070028-01A1 istex:0BD38AB7382AE7D231CBF92F3CA4031E86E57954 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23  | 
| ISSN: | 0277-6715 1097-0258  | 
| DOI: | 10.1002/sim.2225 |